Original Literature | Model OverView |
---|---|
Publication
Title
The role of Toll-like receptors and Nod proteins in bacterial infection.
Affiliation
Immunite Innee et Signalisation, Institut Pasteur, 28 rue du Dr. Roux, 75724Paris 15, France. philpott@pasteur.fr
Abstract
Our understanding of innate immunity in mammals has greatly expanded followingthe discovery of the family of membrane-bound receptors, called the Toll-likereceptors (TLRs). More recently, the nucleotide-binding oligomerisation domain(Nod) molecules, Nod1 and Nod2, which are cytoplasmic surveillance proteins,have also been shown to be involved in the innate immune response. These twoclasses of detection molecules, classified as "pattern recognition receptors"(PRRs), detect microbial ligands in order to initiate a defense response tofight infectious disease. These microbial ligands or "pathogen-associatedmolecular patterns" (PAMPs), detected by TLRs and Nods are often structuralcomponents of the microorganism that are not subject to much variation. Theseinclude such factors as lipopolysaccharide (LPS) and peptidoglycan from the cellwalls of bacteria. In order to understand the role of TLRs and Nod proteins ininfectious disease in vivo it is important to define the site of interactionbetween PRRs and PAMPS. Additionally, the challenge of mice deficient in thevarious PRRs in natural infection models will help to decipher the contributionof these molecules not only in the innate immune response against pathogeninfection but also how these proteins may instruct the adaptive immune responsein order to have a tailored immune response against a particular microbe.
PMID
15476921
|
Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m32
10
infinite
0
TRANSPATH | MO000000058 |
--
IRAK [activated}
--
MO000000213
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m184
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000213 |
--
IkappaB-alpha{p}
--
MO000000220
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m190
10
infinite
0
TRANSPATH | MO000000220 |
--
IkappaB-alpha
--
MO000000233
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m199
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000233 |
--
TLR4
--
MO000019394
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3961
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019394 |
--
TLR2
--
MO000019397
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3964
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019397 |
--
LPS:LBP:CD14
--
MO000021929
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6255
10
infinite
0
TRANSPATH | MO000021929 |
--
flagellin
--
MO000022185
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m6485
10
infinite
0
TRANSPATH | MO000022185 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LTA
--
e11
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m11
0
infinite
0
--
lipoarabinomannan
--
e12
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m12
0
infinite
0
--
PGN: TLR2
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m13
0
infinite
0
--
Lp: TLR2
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m14
0
infinite
0
--
lipoarabinomannan: TLR2
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m15
0
infinite
0
--
LTA: TLR2
--
e16
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m16
0
infinite
0
--
zymosan
--
e17
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m17
0
infinite
0
--
zymosan: TLR2
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m18
0
infinite
0
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
LPG: TLR2
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m20
0
infinite
0
--
flagellin: TLR5
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m21
0
infinite
0
--
HSP: TLR4
--
e22
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m22
0
infinite
0
--
DEFB: TLR4
--
e24
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m24
0
infinite
0
--
LPS: CD14: MD-2: TLR4: MyD88
--
e25
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m25
0
infinite
0
--
TRAF6: IRAK {activated}
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
IKK-alpha:IKK-beta:IKK-gamma
--
e28
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m28
10
infinite
0
TRANSPATH | MO000016661 |
--
IKK-alpha:IKK-beta:IKK-gamma {activated}
--
e29
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m29
10
infinite
0
TRANSPATH | MO000016661 |
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IkappaB-alpha {ub}
--
e30
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m30
10
infinite
0
TRANSPATH | MO000048700 |
--
protein remnants
--
e31
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
NF-kappaB {nucleus}
--
e32
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m33
10
infinite
0
TRANSPATH | MO000000058 |
--
csml-variable:Double
m34
0
infinite
0
--
csml-variable:Double
m35
0
infinite
0
--
csml-variable:Double
m36
0
infinite
0
--
csml-variable:Double
m37
0
infinite
0
--
Nod {oligomer}
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
RIP2: NOD {oligomer}
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
RIP2 {activated}: NOD {oligomer}
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
RIP2 {activated}: NOD {oligomer}: IKK-alpha:IKK-beta:IKK-gamma (n)
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
RIP2 {activated}: NOD {oligomer}: IKK-alpha:IKK-beta:IKK-gamma
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
csml-variable:Double
m43
10
infinite
0
Affymetrix | 108862_f_at |
Ensembl | ENSMUSG00000027832 |
MGD | Ptx3 |
Proteome | HumanPSD/Ptx3 |
RefSeq | NM_008987 |
TRANSFAC | T05664 |
TRANSPATH | MO000039146 |
Unigene | Mm.276776 |
UniProt | P48759 |
--
csml-variable:Double
m45
0
infinite
0
--
IL-12: IL-12R
--
e45
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m46
0
infinite
0
--
S. flexneri
--
e46
cso30:c:Cell
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m47
0
infinite
0
--
pro-inflammatory response genes
--
e47
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m48
0
infinite
0
--
MD-2: TLR4
--
e5
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LPS: CD14: MD-2: TLR4
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c5 : 1
stoichiometry:c2 : 1
m155666*m3985*0.1
nodelay
--
0
PMID: 15476921 LPS binding and signalling through TLR4 involves the LPS binding protein (LBP), CD14 and MD-2.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m19*m3964*0.1
nodelay
--
0
PMID: 15476921, 12946842 More recently, the role of innate immunity in control of this infection has been investigated with the identification of TLR2 as the PRR that detects lipophosphoglycan (LPG), a glycosylphosphatidylinositol (GPI)-anchored glycolipid, and important virulence factor, from the membrane of the parasite.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 15476921 TLR3 detects double-stranded RNA from viruses.
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m6485*m3966*0.1
nodelay
--
0
PMID: 15476921, 11489966 TLR5, which is the PRR that detects flagellin, is expressed only on the basolateral surface of intestinal epithelial cells thus requiring flagellin translocation or bacterial penetration of the epithelial barrier to induce stimulation.
p13
p13
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c39 : 1
stoichiometry:c38 : 1
m3961*m6220*0.1
nodelay
--
0
PMID: 15476921, 10623794, 11150311, 12411706 Heat-shock proteins , a number of extracellular matrix proteins and beta-defensins have been reported to stimulate TLR4 and induce pro-inflammatory signalling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m23*m3961*0.1
nodelay
--
0
PMID: 15476921, 10623794, 11150311, 12411706 Heat-shock proteins , a number of extracellular matrix proteins and beta-defensins have been reported to stimulate TLR4 and induce pro-inflammatory signalling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m6*m1572*0.1
nodelay
--
0
PMID: 15476921 Upon ligand binding to the extracellular portion of these receptors, the TIR domains recruit TIR-containing adaptor molecules, including MyD88.
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c48 : 1
stoichiometry:c47 : 1
m26*m25*0.1
nodelay
--
0
PMID: 15476921 This recruitment process sets up a cascade of further recruitment of adaptor molecules and activation of a number of kinases of the interleukin-1 receptor associated kinase (IRAK) family.
p17
p17
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m184*m183*0.1
nodelay
--
0
PMID: 15476921 Activated IRAK then recruits TRAF6 that ultimately leads to the activation of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m27*m28*0.1
nodelay
--
0
PMID: 15476921 Activated IRAK then recruits TRAF6 that ultimately leads to the activation of the IKK complex.
p19
p19
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c57 : 1
stoichiometry:c56 : 1
m199*m29*0.1
nodelay
--
0
PMID: 15476921 The catalytic subunits of this complex phosphorylate I¦ÊBgreek small letter alpha, the inhibitory molecule that keeps NF-¦ÊappaB in an inactive state in the cytoplasm, and this then targets this molecule for ubiquitination and subsequent degradation by the proteasome.
p2
p2
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c6 : 1
stoichiometry:c4 : 1
m6254*m2828*0.1
nodelay
--
0
PMID: 15476921 LPS binding and signalling through TLR4 involves the LPS binding protein (LBP), CD14 and MD-2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m190*0.1
nodelay
--
0
PMID: 15476921 The catalytic subunits of this complex phosphorylate I¦ÊBgreek small letter alpha, the inhibitory molecule that keeps NF-¦ÊappaB in an inactive state in the cytoplasm, and this then targets this molecule for ubiquitination and subsequent degradation by the proteasome.
p21
p21
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m30*0.1
nodelay
--
0
PMID: 15476921 The catalytic subunits of this complex phosphorylate I¦ÊBgreek small letter alpha, the inhibitory molecule that keeps NF-¦ÊappaB in an inactive state in the cytoplasm, and this then targets this molecule for ubiquitination and subsequent degradation by the proteasome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m32*0.1
nodelay
--
0
PMID: 15476921 NF-¦ÊappaB is then free to translocate to the nucleus and drive the expression of genes, many of which are involved in the pro-inflammatory response.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c69 : 1
m34*m4923*0.1
nodelay
--
0
PMID: 15476921, 12791997 We recently demonstrated that Nod1 senses GlcNAc-MurNAc-L-Ala-¦Ã-D-Glu-meso-DAP (GM-triDAP), a naturally occurring PGN degradation product.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c70 : 1
m35*m4947*0.1
nodelay
--
0
PMID: 15476921, 12527755, 12514169 In contrast to Nod1, Nod2 has been implicated as a general sensor for both Gram-positive and Gram-negative bacteria since biochemical and functional analyses have identified muramyl dipeptide MurNAc-L-Ala-D-isoGln (MDP), the minimal motif in all PGNs, as the essential structure recognized by Nod2. PMID: 15476921, 12527755, 12514169 Nod2 can detect the minimal structure of PGN, which is MDP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m20159*0.1
nodelay
--
0
PMID: 15476921 Over-expression leads to auto-oligomerization of these molecules through the NBS region.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c97 : 1
stoichiometry:c75 : 1
m38*m2684*m47*0.1
nodelay
--
0
PMID: 15476921, 9575181, 9642260, 11423652 It is believed that this process potentially exposes the CARD domain that can then interact with the CARD domain of a serine/threonine kinase called RIP2 (also known and RICK or CARDIAK). PMID: 15476921 Biochemical analysis has revealed that RIP2 interacts with both Nod1 and Nod2 and mediates the activation of NF-¦ÊappaB by these molecules. PMID: 15476921, 11463746 Using an in vitro model of infection, we could show that infection of epithelial cells with S. flexneri is a physiological stimulus leading to recruitment and interaction of RIP2 with Nod1 leading to the subsequent activation of NF-B
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m39*0.1
nodelay
--
0
PMID: 15476921, 10880512 This recruitment process leads to the activation of RIP2 by a mechanism referred to as ¡Èinduced proximity¡É.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c78 : 1
stoichiometry:c80 : 1
m40*m28*0.1
nodelay
--
0
PMID: 15476921, 10880512 RIP2 is likely activated following recruitment to Nod molecules allowing it to then interact with the regulatory subunit of the IKK complex, IKKgamma or NEMO.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m42*0.1
nodelay
--
0
PMID: 15476921 Again, it appears that oligomerization of IKKgamma through interactions with RIP2 induces the activation of the catalytic domains of the complex, IKKalpha and IKKbeta, leading to the phosphorylation of I¦ÊappaB-alpha, subsequent degradation of this molecule and release of NF-¦ÊappaB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m6438*m3961*0.1
nodelay
--
0
PMID: 15476921 LPS binding and signalling through TLR4 involves the LPS binding protein (LBP), CD14 and MD-2.
p30
p30
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c85 : 1
stoichiometry:c84 : 1
m199*m41*0.1
nodelay
--
0
PMID: 15476921 Again, it appears that oligomerization of IKKgamma through interactions with RIP2 induces the activation of the catalytic domains of the complex, IKKalpha and IKKbeta, leading to the phosphorylation of I¦ÊappaB-alpha, subsequent degradation of this molecule and release of NF-¦ÊappaB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m43*m44*0.1
nodelay
--
0
PMID: 15476921 PTX3 participates in the complement cascade by binding to C1q and was shown to also interact with a number of microbes including A. fumigatus.
p32
p32
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m93423*m46*0.1
nodelay
--
0
PMID: 15476921, 11894097, 11894098 RIP2-deficient mice have impaired production of IFN-gamma following stimulation of cells with IL-12.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c89 : 1
m46*0.1
nodelay
--
0
PMID: 15476921, 11894097, 11894098 RIP2-deficient mice have impaired production of IFN-gamma following stimulation of cells with IL-12.
p34
p34
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c93 : 1
m2121*m12340*0.1
nodelay
--
0
PMID: 15476921, 11894097, 11894098 RIP2-deficient mice have impaired production of IFN-gamma following stimulation of cells with IL-12.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
m33*0.1
nodelay
--
0
PMID: 15476921 NF-B is then free to translocate to the nucleus and drive the expression of genes, many of which are involved in the pro-inflammatory response.
p4
p4
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m6255*m5*0.1
nodelay
--
0
PMID: 15476921 LPS binding and signalling through TLR4 involves the LPS binding protein (LBP), CD14 and MD-2.
p5
p5
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c21 : 1
m3964*m155701*0.1
nodelay
--
0
PMID: 15476921 TLR2 has been shown to recognise a number of different PAMPs, including LTA and PGN from Gram-positive bacteria, lipoproteins from Gram-negative bacteria, lipoarabinomannan from Mycobacteria spp. and zymosan, a component of the cell wall from yeast.
p6
p6
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c24 : 1
m11*m3964*0.1
nodelay
--
0
PMID: 15476921 TLR2 has been shown to recognise a number of different PAMPs, including LTA and PGN from Gram-positive bacteria, lipoproteins from Gram-negative bacteria, lipoarabinomannan from Mycobacteria spp. and zymosan, a component of the cell wall from yeast.
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c22 : 1
m3964*m2549*0.1
nodelay
--
0
PMID: 15476921 TLR2 has been shown to recognise a number of different PAMPs, including LTA and PGN from Gram-positive bacteria, lipoproteins from Gram-negative bacteria, lipoarabinomannan from Mycobacteria spp. and zymosan, a component of the cell wall from yeast.
p8
p8
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c23 : 1
m3964*m12*0.1
nodelay
--
0
PMID: 15476921 TLR2 has been shown to recognise a number of different PAMPs, including LTA and PGN from Gram-positive bacteria, lipoproteins from Gram-negative bacteria, lipoarabinomannan from Mycobacteria spp. and zymosan, a component of the cell wall from yeast.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m3964*m17*0.1
nodelay
--
0
PMID: 15476921 TLR2 has been shown to recognise a number of different PAMPs, including LTA and PGN from Gram-positive bacteria, lipoproteins from Gram-negative bacteria, lipoarabinomannan from Mycobacteria spp. and zymosan, a component of the cell wall from yeast.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--